# Pillar Biosciences

Source: https://onco.cc/companies/pillar-biosciences/  
OnCo record `pillar-biosciences` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Massachusetts maker of sequencing panels whose ONCO/Reveal Dx assay is an FDA companion diagnostic in bowel and lung cancer.

## Summary

Pillar Biosciences makes sequencing panels for solid tumour tissue, liquid biopsy and blood cancers. Its ONCO/Reveal Dx Lung & Colon Cancer Assay was approved by the FDA in July 2021 as a companion diagnostic for KRAS wild-type colorectal cancer (cetuximab, panitumumab) and for EGFR-mutant lung cancer (approved EGFR inhibitors).

## Fields

- Kind: Company
- Last checked: 2026-11-03
- HQ: Natick, MA
- Type: diagnostics
- Website: https://www.pillarbiosci.com

## Sources

- Official website: https://www.pillarbiosci.com
- FDA PMA P200011: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P200011

## Connected records

- cancers: [Colorectal cancer](https://onco.cc/cancers/colorectal/), [Non-small-cell lung cancer](https://onco.cc/cancers/nsclc/)
- fronts: [Diagnostics & Biomarkers](https://onco.cc/fronts/diagnostics/)
- technologies: [Companion diagnostics](https://onco.cc/technologies/companion-diagnostic/)
- drugs: [ONCO/Reveal Dx Lung and Colon Cancer Assay](https://onco.cc/drugs/onco-reveal-dx-lung-colon/)

---
JSON: https://onco.cc/api/v1/entities/pillar-biosciences.json